Phathom Pharmaceuticals Inc (PHAT)
10.36
-0.45
(-4.16%)
USD |
NASDAQ |
Jun 25, 16:00
10.36
0.00 (0.00%)
Pre-Market: 20:00
Phathom Pharmaceuticals Cash and Short Term Investments (Quarterly): 322.23M for March 31, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 322.23M |
| December 31, 2023 | 381.39M |
| September 30, 2023 | 213.68M |
| June 30, 2023 | 248.85M |
| March 31, 2023 | 129.57M |
| December 31, 2022 | 155.38M |
| September 30, 2022 | 196.84M |
| June 30, 2022 | 207.39M |
| March 31, 2022 | 138.09M |
| December 31, 2021 | 183.26M |
| September 30, 2021 | 224.62M |
| Date | Value |
|---|---|
| June 30, 2021 | 209.67M |
| March 31, 2021 | 237.97M |
| December 31, 2020 | 287.50M |
| September 30, 2020 | 226.36M |
| June 30, 2020 | 247.27M |
| March 31, 2020 | 256.67M |
| December 31, 2019 | 243.76M |
| September 30, 2019 | 74.48M |
| June 30, 2019 | 82.92M |
| December 31, 2018 | 0.879M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
74.48M
Minimum
Sep 2019
381.39M
Maximum
Dec 2023
213.40M
Average
219.15M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Insmed Inc | 595.73M |
| Regeneron Pharmaceuticals Inc | 10.52B |
| Rocket Pharmaceuticals Inc | 330.31M |
| Rhythm Pharmaceuticals Inc | 201.20M |
| Xeris Biopharma Holdings Inc | 87.35M |